Key result
Adult-diagnosed congenital myopathies show characteristic biopsy features in only ~55% of patients.
Why the study?
The spectrum of undiagnosed congenital myopathies in adults and the pitfalls responsible for diagnostic delays needed to be investigated.
Cohort (n=44)
No
Adults with congenital myopathies frequently present with progressive weakness, elevated CK, cardiomyopathy (29%), and nonspecific muscle biopsy findings, supporting early use of next-generation sequencing panels to prevent misdiagnosis and diagnostic delay.
Answers are grounded in this paper and cite their sources.
Nonspecific biopsies and frequent misdiagnoses occur in adult-diagnosed congenital myopathies; challenges biopsy-centric paradigms and leaves open genetic testing strategies.
Objective To investigate the spectrum of undiagnosed congenital myopathies (CMs) in adults presenting to our neuromuscular clinic and to identify the pitfalls responsible for diagnostic delays. Methods We conducted a retrospective review of patients diagnosed with CM in adulthood in our neuromuscular clinic between 2008 and 2018. Patients with an established diagnosis of CM before age 18 years were excluded. Results We identified 26 patients with adult-onset CM and 18 patients with pediatric-onset CM who were only diagnosed in adulthood. Among patients with adult onset, the median age at onset was 47 years, and the causative genes were RYR1 (11 families), MYH7 (3 families) and ACTA1 (2 families), and SELENON, MYH2, DNM2, and CACNA1S (1 family each). Of 33 patients who underwent muscle biopsy, only 18 demonstrated histologic abnormalities characteristic of CM. Before their diagnosis of CM, 23 patients had received other diagnoses, most commonly non-neurologic disorders. The main causes of diagnostic delays were mildness of the symptoms delaying neurologic evaluation and attribution of the symptoms to coexisting comorbidities, particularly among pediatric-onset patients. Conclusions CMs in adulthood represent a diagnostic challenge, as they may lack the clinical and myopathologic features classically associated with CM. Our findings underscore the need for a revision of the terminology and current classification of these disorders.
No takes yet. Share an insight, caveat, or question.
Nicolau et al. (2019) conducted a cohort in Congenital myopathies diagnosed in adulthood (n=44). Congenital myopathy diagnosed in adulthood (genetic testing and muscle biopsy evaluation) was evaluated on Characteristic histologic abnormalities of congenital myopathy on muscle biopsy. Congenital myopathies diagnosed in adulthood showed characteristic histologic abnormalities in only 18 of 33 biopsied patients and prior misdiagnoses in 23 of 44 patients.
Synapse has enriched 10 related papers. Consider them for comparative context: